Filter
750
Filtered Results: 750
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
189
Language
Document type
No document type
370
Studies & Reports
148
Guidelines
126
Manuals
38
Strategic & Response Plan
37
Fact sheets
12
Situation Updates
8
Training Material
5
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
36
Global
33
Kenya
32
Ghana
20
Nigeria
20
Uganda
19
Ethiopia
18
Western and Central Europe
14
South Africa
14
Sierra Leone
13
Bangladesh
13
Nepal
12
Tanzania
12
Zambia
12
Africa
10
Lesotho
9
Malawi
9
Botswana
9
Ukraine
8
Zimbabwe
8
Liberia
8
South–East Asia Region
7
Namibia
7
Myanmar / Burma
7
Rwanda
6
Philippines
6
Latin America and the Carribbean
6
Eastern Europe
5
Indonesia
5
Eswatini/ Swaziland
4
Tajikistan
3
Thailand
3
Albania
3
Haiti
3
Cambodia
3
West and Central Africa
3
East and Southern Africa
3
Russia
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
Asia
2
Germany
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Moldova
2
Sudan
2
Pakistan
2
Serbia
1
Australia
1
Benin
1
China
1
Syria
1
Burkina Faso
1
Uzbekistan
1
Mongolia
1
Guinea
1
USA
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Turkmenistan
1
Maldives
1
Mauritius
1
Vietnam
1
Brazil
1
Sri Lanka
1
South Sudan
1
Iraq
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
305
Clinical Guidelines
62
Public Health
30
Pharmacy & Technologies
30
Key Resources
20
Women & Child Health
13
Capacity Building
5
Toolboxes
Pharmacy
86
AMR
85
COVID-19
54
HIV
48
TB
39
Mental Health
34
NTDs
21
Planetary Health
17
Rapid Response
14
Ebola & Marburg
14
NCDs
14
Health Financing Toolbox
12
Global Health Education
12
Specific Hazards
6
Caregiver
6
Conflict
5
Cholera
4
Natural Hazards
3
Malaria
3
Polio
2
Refugee
1
Disability
1
Zika
1
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply...
Three Years After Enactment of the Drug Quality and Security Act
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug ...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3: Drug-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdd...
World Drug Report 2018
-3-
World Drug Report 2018
-2-
The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i...
World Drug Report 2017
-5-
Accessed: 14.03.2019
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Strategic Overview
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us...
